Lorri L. Short
Eli Lilly (United States)(US)
Publications by Year
Research Areas
Estrogen and related hormone effects, Menopause: Health Impacts and Treatments, Inflammatory mediators and NSAID effects, Organic Chemistry Cycloaddition Reactions, Systemic Lupus Erythematosus Research
Most-Cited Works
- → Discovery and Synthesis of [6-Hydroxy-3-[4-[2-(1-piperidinyl)ethoxy]phenoxy]- 2-(4-hydroxyphenyl)]benzo[b]thiophene: A Novel, Highly Potent, Selective Estrogen Receptor Modulator(1997)176 cited
- → Structure−Activity Relationships of Selective Estrogen Receptor Modulators: Modifications to the 2-Arylbenzothiophene Core of Raloxifene(1997)175 cited
- → Environmental estrogens: Effects on cholesterol lowering and bone in the ovariectomized rat(1996)149 cited
- → Synthesis and Pharmacology of Conformationally Restricted Raloxifene Analogues: Highly Potent Selective Estrogen Receptor Modulators(1998)126 cited
- → Longitudinal and cross-sectional analysis of raloxifene effects on tibiae from ovariectomized aged rats.(1995)120 cited
- → A role for CD8+ T lymphocytes in osteoclast differentiation in vitro.(1996)90 cited
- → Raloxifene is a Tissue‐Selective Agonist/Antagonist That Functions through the Estrogen Receptor(1995)87 cited
- In vivo modulation of murine serum tumour necrosis factor and interleukin-6 levels during endotoxemia by oestrogen agonists and antagonists.(1995)
- → Estriol: A potent regulator of TNF and IL-6 expression in a murine model of endotoxemia(1996)57 cited
- → Evaluation of the major metabolites of raloxifene as modulators of tissue selectivity(1997)55 cited